Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia

Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia

Abstract Objective Preterm infants are at a high risk of developing BPD. Although progression in neonatal care has improved, BPD still causes significant morbidity and mortality, which can be attributed to the limited therapeutic choices for BPD. This review discusses the potential of MSC in treatin...

Full description

Bibliographic Details
Main Authors: Eireen Tang, Mariam Zaidi, Wen‐Huey Lim, Vijayendran Govindasamy, Kong‐Yong Then, Khong‐Lek Then, Anjan Kumar Das, Soon‐Keng Cheong
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:The Clinical Respiratory Journal
Subjects:
chronic lung department
extremely low gestational age newborns (ELGANs)
mesenchymal stem cells
PNEUMOSTEM
preterm infants
respiratory diseases
Online Access:https://doi.org/10.1111/crj.13540

Internet

https://doi.org/10.1111/crj.13540

Similar Items